Search

Your search keyword '"Cardiac patients -- Patient outcomes -- Care and treatment"' showing total 12 results
Start Over Descriptor "Cardiac patients -- Patient outcomes -- Care and treatment" Publisher comtex news network, inc.
12 results on '"Cardiac patients -- Patient outcomes -- Care and treatment"'

1. NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiovascular Disease

Subjects
Cholesterol -- Forecasts and trends, Cardiovascular agents -- Evaluation, Cardiovascular diseases -- Care and treatment -- Patient outcomes, Cardiac patients -- Patient outcomes -- Care and treatment, Low density lipoproteins -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

NAARDEN, the Netherlands and MIAMI, April 09, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or 'NewAmsterdam' or the 'Company'), a late-stage, clinical biopharmaceutical company developing oral, non-statin [...]

Published
2024

2. Heart & Vascular Institute Selects CareCloud's Chronic Care Management Program to Empower Patients with Personalized Care Plans and Improve Health Outcomes

Subjects
Cardiac patients -- Patient outcomes -- Care and treatment, Company business management, Banking, finance and accounting industries, Business
Abstract

SOMERSET, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=Vz6A-mL8XxfZuQLA7P8BO1dDzF4-eb88CnDqOqqHJ2-vhAOJQcdFKCNhiVPQch4pudBquEeQfIoxi0px9aUHaA== (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that the [...]

Published
2023

3. New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device

Subjects
Daxor Corp., Blood -- Medical examination, Transplantation of organs, tissues, etc., Medical test kit industry, Medical equipment and supplies industry, Heart, Cardiac patients -- Patient outcomes -- Care and treatment, Heart failure -- Care and treatment -- Patient outcomes, Banking, finance and accounting industries, Business
Abstract

Oak Ridge, TN, May 02, 2022 (GLOBE NEWSWIRE via COMTEX) -- Study Presented at the International Society for Heart and Lung Transplant 42 Annual Meeting and Scientific Sessions 2022 DaxorCorporation [...]

Published
2022

4. Philips adds to its cardiology suite of solutions at ACC 2022 with innovations to help improve patient outcomes, experiences, and care pathway effectiveness

Subjects
Coronary heart disease -- Care and treatment -- Patient outcomes, Cardiology, Cardiac patients -- Patient outcomes -- Care and treatment, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- March 31, 2022 Innovations designed to seamlessly work together, strengthen clinical confidence, build efficiency throughout the care pathway, and improve cardiac care experiences Amsterdam, the [...]

Published
2022

5. International Journal of Cardiology Publishes Data Demonstrating Superior Outcomes of Stereotaxis Robotic Cardiac Ablation in Pediatric Patients

Subjects
Medical research -- Technology application, Medicine, Experimental -- Technology application, Ablation (Surgery) -- Technology application, Pediatric cardiology -- Technology application, Children -- Health aspects, Tachycardia -- Care and treatment -- Patient outcomes, Heart -- Technology application, Cardiac patients -- Patient outcomes -- Care and treatment, Technology application, Banking, finance and accounting industries, Business
Abstract

ST. LOUIS, Oct 12, 2021 (GLOBE NEWSWIRE via COMTEX) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication [...]

Published
2021

6. Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images

Subjects
Koninklijke Philips N.V., Balloon angioplasty, Coronary heart disease -- Patient outcomes -- Care and treatment, Medical research, Cardiac patients -- Patient outcomes -- Care and treatment, Angiography, Technology, Arteries, Diseases, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- February 11, 2020 - Randomized controlled trial with up to 3,000 participants at 75 sites to compare outcomes between physiological guidance by iFR data co-registered [...]

Published
2020

7. Esperion Completes Patient Enrollment in the Global CLEAR Cardiovascular Outcomes Trial for Bempedoic Acid

Subjects
United States. Food and Drug Administration, Esperion Therapeutics Inc., Clinical trials, Ezetimibe, Statins, Cardiac patients -- Patient outcomes -- Care and treatment, Pharmaceutical industry, Cardiovascular agents, Cardiovascular diseases -- Patient outcomes -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

ANN ARBOR, Mich., Sep 05, 2019 (GLOBE NEWSWIRE via COMTEX) -- - 14,032 Patients are Now Fully Enrolled in the CLEAR Cardiovascular Outcomes Trial - - Expect CLEAR Cardiovascular Outcomes [...]

Published
2019

8. Amarin randomizes all patients under REDUCE-IT cardiovascular outcomes study of Vascepa

Subjects
Medical research, Cardiac patients -- Patient outcomes -- Care and treatment, Cardiovascular agents -- Research, Cardiovascular diseases -- Research -- Patient outcomes -- Care and treatment, General interest, News, opinion and commentary
Abstract

Sep 02, 2016 (M2 EQUITYBITES via COMTEX) -- Biopharmaceutical company Amarin (NasdaqGM:AMRN) reported on Wednesday the randomisation of the last patient as part of the REDUCE-IT cardiovascular outcomes study of [...]

Published
2017

9. Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee

Subjects
Amarin Corporation PLC, Statins, Biotechnology industries, Medical research, Cardiac patients -- Patient outcomes -- Care and treatment, Cardiovascular agents, Cardiovascular diseases -- Patient outcomes -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

BEDMINSTER, N.J. and DUBLIN, Ireland, Sep 12, 2016 (GLOBE NEWSWIRE via COMTEX) -- Amarin Corporation plc (NASDAQ:AMRN) announced that, as expected, the independent data monitoring committee (DMC) has completed its [...]

Published
2016

11. Independent Multicenter Trial Demonstrates Utility of BGM Galectin-3(R) Test for Accurately Classifying Risk of Unplanned Hospital Readmissions and Adverse Outcomes in Patients With Heart Failure

Subjects
Clinical trials, Cardiac patients -- Patient outcomes -- Care and treatment, Heart failure -- Patient outcomes -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

WALTHAM, Mass., Nov 19, 2013 (GLOBE NEWSWIRE via COMTEX) -- BG Medicine, Inc. (Nasdaq:BGMD) announced today the publication of results of an independent multicenter clinical research trial in Europe that [...]

Published
2013

12. Amarin Announces Dosing of First Patient in Cardiovascular Outcomes Study REDUCE-IT

Subjects
United States. Food and Drug Administration, Amarin Corporation PLC, Biological products industry, Cardiovascular agents, Medical research, Medicine, Experimental, Statins, Cardiovascular diseases -- Patient outcomes -- Care and treatment, Cardiac patients -- Patient outcomes -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

Byline: Staff BEDMINSTER, N.J., and DUBLIN, Ireland, Dec 7, 2011 (GlobeNewswire via COMTEX) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company with a focus on cardiovascular disease, today announced [...]

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results